Loading chat...

HI SB40

Bill

Status

Vetoed

7/12/2011

Primary Sponsor

Clarence Nishihara

Click for details

Origin

Senate

2011 Regular Session

AI Summary

  • Expands pseudoephedrine sales regulations to include ephedrine and establishes daily (3.6 grams) and monthly (9 grams per 30-day period) purchase limits for over-the-counter products.

  • Requires pharmacies and retailers to maintain records including purchaser information, identification details, product name, and amount of sale, with records retained for two years.

  • Mandates electronic submission of sales data beginning January 1, 2012 to the National Precursor Log Exchange administered by the National Association of Drug Diversion Investigators, with system stop-sale alerts when limits are exceeded.

  • Allows pharmacies to seek exemptions from the Board of Pharmacy for up to 180 days and requires alternative written logs during system failures or exemption periods.

  • Requires wholesalers to report all sales of pseudoephedrine and ephedrine products to retailers, and establishes class C felony penalties for violations and misdemeanor penalties for retailers failing to transmit required information.

Legislative Description

Pseudoephedrine; Tracking

Last Action

(S) Vetoed on 07-12-11 - Returned from the Governor without approval (Gov. Msg. No. 1347).

7/12/2011

Committee Referrals

Judiciary and Labor2/18/2011
Health1/21/2011

Full Bill Text

No bill text available